These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 7524238

  • 1. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer.
    Grob BM, Schellhammer PF, Brassil DN, Wright GL.
    Urology; 1994 Oct; 44(4):525-9. PubMed ID: 7524238
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
    Hakalahti L, Vihko P, Henttu P, Autio-Harmainen H, Soini Y, Vihko R.
    Int J Cancer; 1993 Oct 21; 55(4):590-7. PubMed ID: 7691762
    [Abstract] [Full Text] [Related]

  • 4. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
    Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfert RL, Young CY, Klee GG, Tindall DJ, Bostwick DG.
    Urology; 1997 Jun 21; 49(6):857-62. PubMed ID: 9187691
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.
    Gallee MP, Visser-de Jong E, van der Korput JA, van der Kwast TH, ten Kate FJ, Schroeder FH, Trapman J.
    Urol Res; 1990 Jun 21; 18(3):181-7. PubMed ID: 1697709
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prostate-specific antigen in the follow-up of prostatic adenocarcinoma treated with external beam radiation.
    Kellokumpu-Lehtinen P, Nurmi M, Koskinen P, Irjala K.
    Urol Int; 1991 Jun 21; 46(1):6-8. PubMed ID: 1708923
    [Abstract] [Full Text] [Related]

  • 11. Prostate inhibin peptide (PIP) in prostate cancer: a comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP).
    Garde SV, Sheth AR, Venkatesan VM, Panchal CJ, Porter AT, Grignon DJ.
    Cancer Lett; 1994 Apr 01; 78(1-3):11-7. PubMed ID: 7514089
    [Abstract] [Full Text] [Related]

  • 12. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A, Ersev D, Turkeri L, Ilker Y, Simsek F, Kullu S, Akdas A.
    Prog Clin Biol Res; 1990 Apr 01; 357():129-34. PubMed ID: 1699237
    [Abstract] [Full Text] [Related]

  • 13. DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma.
    Berner A, Waere H, Nesland JM, Paus E, Danielsen HE, Fosså SD.
    Br J Urol; 1995 Jan 01; 75(1):26-32. PubMed ID: 7531589
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
    Abrahamsson PA, Lilja H, Falkmer S, Wadström LB.
    Prostate; 1988 Jan 01; 12(1):39-46. PubMed ID: 2450341
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line.
    Henttu P, Vihko P.
    J Steroid Biochem Mol Biol; 1992 Mar 01; 41(3-8):349-60. PubMed ID: 1373297
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prostate-specific antigen as a marker of adenocarcinoma of prostate.
    Kellokumpu-Lehtinen P, Nurmi M, Koskinen P, Irjala K.
    Urol Res; 1989 Mar 01; 17(4):245-9. PubMed ID: 2475959
    [Abstract] [Full Text] [Related]

  • 20. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z, Wenlu S.
    Prostate; 2007 May 01; 67(6):653-60. PubMed ID: 17342746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.